Former CDC leaders urge Congress to reject overseas Ebola quarantine plan
Former CDC leaders warned Congress that sending Ebola-exposed Americans to Kenya would weaken repatriation norms and shake trust in U.S. outbreak response.
Experienced U.S. health officials are pressing Congress to reject a proposal that would move Americans exposed to Ebola to quarantine or treatment sites in Kenya or the European Union instead of bringing them back to the United States. In an open letter sent June 1, former CDC leaders and other physicians said the plan would break with the long-standing practice of medical repatriation, where exposed patients are flown home quickly and managed under U.S. medical supervision.
The signers included infectious disease physician Krutika Kuppalli, emergency physicians Debra Houry and Craig Spencer, and epidemiologist Anne Schuchat. Their warning was blunt: shifting care overseas could create serious clinical, ethical, operational and legal risks, and it could set a dangerous precedent for future outbreaks. The officials argued that if frontline responders believe they may be quarantined or treated abroad, some may hesitate to deploy to outbreak zones at all, weakening the broader global response at a moment when containment is already strained.
The dispute has intensified around a U.S.-backed plan for a 50-bed facility at a Kenyan air force base in Laikipia County. Kenyan authorities had provided written approval on May 28, but a Kenyan high court temporarily suspended the plan after a lawsuit said the site could endanger public health. Hundreds of protesters also took to the streets in Nanyuki on June 1 to oppose the project. The Kenya Ministry of Health has described talks with the United States and other partners, but has not publicly framed the arrangement as an endorsement of the quarantine center.

The policy fight is unfolding as the World Health Organization tracks an Ebola outbreak in the Democratic Republic of the Congo and Uganda that was confirmed in May 2026. WHO said the outbreak involves the Bundibugyo species of Ebola, for which there is no vaccine or specific treatment, and reported 906 suspected cases and 223 suspected deaths under investigation as of May 29. That combination of high stakes and limited treatment options has made every decision about movement, quarantine and treatment deeply sensitive.
The United States has already shown it can move Ebola patients and exposed Americans to Europe for monitoring and treatment. In May, an American doctor with Ebola was flown from the DRC to Germany, and CDC officials said six other high-risk U.S. citizens were being moved to Germany and the Czech Republic for monitoring. The CDC says thousands of its staff contributed to the 2014-2016 West Africa Ebola response, underscoring the country’s long institutional memory on repatriation.

Still, critics say a new containment unit in Kenya would signal a retreat from established outbreak norms. The Infectious Diseases Society of America called the idea “deeply concerning,” and the larger issue now is not only where Americans might be treated, but whether U.S. policy still reflects confidence in its own biocontainment capacity.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Did this article answer your question?


